Ribociclib

본문 바로가기
Home > Product > Ribociclib
Selling leads
Ribociclib
Posting date : Mar 11, 2026
Membership
Free Member Scince Jul 07, 2025
FOB Price
$311.5
Min. Order Quantity
10g
Supply Abillity
Stock
Port
Ningbo
Payment Terms
T/T 100%
Package
1g,10g,20g,
Keyword :
chemical
Category
Contact
Lunar
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Jinlan
HS-CODE
-
Package & Delivery Lead Time
Package
1g,10g,20g,
Detailed Description

Approved Indications

  • HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
    • Aromatase inhibitors
    • Fulvestrant

Key Features

  • Potent and selective CDK4/6 inhibition
  • Established overall survival benefit in HR+/HER2- advanced breast cancer
  • Oral, once-daily administration
  • Well-documented safety and clinical data

Applications

API, intermediates, reference standards for R&D, generic registration and commercial manufacturing.

Short English Sales Copy (LinkedIn / Email)

Ribociclib (CAS 1211441-98-3)
Highly selective oral CDK4/6 inhibitor for HR+/HER2- advanced breast cancer.
We supply high-purity Ribociclib API & intermediates for global pharmaceutical R&D and production.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top